With the support of advanced technologies, Novartis in Slovenia develops and manufactures innovative medicines to address diseases for which there remains a significant unmet medical need. Our goal is to improve and extend people’s lives.
We are a leading provider of medicines in the domestic market and an important partner of the Slovenian healthcare system. We operate through two companies - Novartis d.o.o. and Novartis Pharma Services Inc., Branch in Slovenia - at two main locations in Ljubljana and Mengeš. Together, we employ more than 4,300 associates.
Important role within the global Novartis network
Novartis in Slovenia has exceptional development capabilities. In the development and manufacturing of innovative medicines, we leverage the scale of our operations, our expertise, and our technological and organizational strengths. Across various stages of development, manufacturing, and services, we support approximately half of Novartis’ priority innovative products for patients worldwide and are involved in all five of Novartis’ high‑technology platforms. All key Novartis innovative medicines are also available to patients in Slovenia.
Our locations and experts in Slovenia make a significant contribution to technological progress and innovative approaches, enabling the development of Novartis medicines with high value for patients around the world.
We are also highly effective in managing complex product transfers from development to manufacturing. In recent years, we have evolved into an important hub for supporting key global launches and ensuring a stable supply of medicines to global markets.
The development of innovative solutions requires the integration of knowledge and experience. That is why we work closely with scientific and research institutions in Slovenia and abroad and, together with our partners, contribute to the development of Slovenian society and the economy.
